A new study led by Ananda Basu, M.D., used novel non-radioactive, stable glucagon tracers for the first time to characterize glucagon metabolism in humans with and without Type 1 diabetes, providing ...

For adults with overweight or obesity, certain factors might influence weight loss after taking glucagon-like peptide 1 ...

A study in Diabetes, Obesity and Metabolism has identified certain characteristics that might influence people's weight loss ...

A new study led by Ananda Basu, M.D., used novel non-radioactive, stable glucagon tracers for the first time to characterize glucagon metabolism in humans with and without Type 1 diabetes, providing ...

A new study finds four factors that may make it more likely for some people to experience successful weight loss from using ...

A study in Diabetes, Obesity and Metabolism has identified certain characteristics that might influence people's weight loss ...

Oxyntomodulin (OXM) is a peptide hormone released by intestinal L cells after food intake. It acts as a dual agonist of glucagon-like peptide 1 (GLP-1) and glucagon receptors, regulating appetite, ...

In a recent study published in the journal Obesity, researchers discuss the role of enhanced visceral adipose tissue (VAT) metabolism in mediating weight loss by glucagon-like peptide-1 (GLP-1) drugs.